Bizollon C A, Rocher J P, Chevalier P
Eur J Nucl Med. 1982;7(7):318-21. doi: 10.1007/BF00253428.
A method for radioimmunoassay of nicergoline (Sermion) in plasma and urine is described. The antiserum was produced in rabbits by administration of an immunogen obtained by coupling bovine serum albumin to the nicergoline molecule at the indole nitrogen. The resulting antibodies reacted well with nicergoline and the 1-demethyl derivative and did not cross-react with the principal metabolites of these substrates nor with rye ergot derivatives in particular dihydroergotamine, methysergide and bromocriptine. The tracer was nicergoline labelled with iodine-125. The assay was sensitive because concentrations as low as 125 X 10-12 mol/l nicergoline could be directly determined in plasma and urine without prior extraction. The marked specificity and high sensitivity allowed easy determination of plasma and urine levels of this drug following administration in man.
本文描述了一种血浆和尿液中尼麦角林(喜得镇)的放射免疫分析方法。通过将牛血清白蛋白与吲哚氮处的尼麦角林分子偶联获得免疫原,然后将其注射到兔子体内产生抗血清。所产生的抗体与尼麦角林及其1 - 去甲基衍生物反应良好,且不与这些底物的主要代谢产物发生交叉反应,也不与黑麦麦角衍生物特别是二氢麦角胺、甲基麦角新碱和溴隐亭发生交叉反应。示踪剂是用碘 - 125标记的尼麦角林。该分析方法具有灵敏性,因为血浆和尿液中低至125×10⁻¹² mol/l的尼麦角林浓度无需预先提取即可直接测定。显著的特异性和高灵敏性使得在人体给药后能够轻松测定该药物的血浆和尿液水平。